Home
Point of Care: Innovations of the Future
23 October - 24 October 2013
Point of Care: Innovations of the Future

The early days of medicine were very similar to point-of-care in that healthcare was delivered in the patients home. The shift towards specialised laboratories and healthcare centres led to a more curative approach to medicine The rapid advancement in technology over the last 20 years has caused this dynamic to shift towards a non-laboratory setting with the ability to perform rapid and accurate diagnostic tests on a patients condition. The shift from curative to preventative approaches to Point of Care can now be enabled by rapid gene sequencing techniques and early detection through microfluidic devices and lab-on-a-chip technology.

So what does the future hold for POC? Join SAE Media Group as we take a look at the future advancements within the field of Point of Care Diagnostics and look to identify POC trends and market opportunities in this ever changing and dynamic field of medicine.

FEATURED SPEAKERS

Penny Wilson

Penny Wilson

Lead Specialist, Detection and Identification Of Infectious Agents, Technology Strategy Board
Phil Lefebvre

Phil Lefebvre

Sr. Manager, Technical Assessment,
Till Bachmann

Till Bachmann

COO, Head of Biochip Research, University of Edinburgh
Tony Gibson

Tony Gibson

Scientific Director, Gateshead Healthcare Nhs Trust

Brian Winn

Partner, Bitecic
Brian Winn

Christopher Lowe

Director of the Institute of Biotechnology, Cambridge University
Christopher Lowe

David Wells

Lead Laboratory Manager and Lead Healthcare Scientist, Great Ormond Street Hospital
David  Wells

David Huckle

Chief Executive, Adams Business Associates
David Huckle

John Clarkson

Chief Executive, ATLAS GENETICS LTD
John Clarkson

John Rippeth

Principal Consultant, PA Consulting Group
John Rippeth

Jose Costa-Fernandez

Vice Dean of the Faculty of Chemistry, University of Oviedo
Jose Costa-Fernandez

Maurice O'Kane

Consultant, Altnagelvin Hospital
Maurice O'Kane

Mohammad Al-Ubaydli

CEO, Patients Know Best
Mohammad Al-Ubaydli

Nigel Sansom

Senior Manager, NHS National Innovation Centre
Nigel Sansom

Penny Wilson

Lead Specialist, Detection and Identification Of Infectious Agents, Technology Strategy Board
Penny Wilson

Per Simonsson

Professor, University Hospital MAS
Per Simonsson

Phil Lefebvre

Sr. Manager, Technical Assessment,
Phil Lefebvre

Richard Luxton

Director of the Institute of Bio-Sensing Technology, University Of The West Of England Bristol
Richard Luxton

Roger Peck

Research Scientist, PATH
Roger Peck

Till Bachmann

COO, Head of Biochip Research, University of Edinburgh
Till Bachmann

Tony Gibson

Scientific Director, Gateshead Healthcare Nhs Trust
Tony Gibson

Conference agenda

clock

8:30

Registration & Coffee

clock

9:00

Chairman's Opening Remarks

David Huckle

David Huckle, Chief Executive, Adams Business Associates

clock

9:10

Is POCT the future of Diagnostics?

  • POCT not a technology but has technology demands
  • Applications of POCT and Market segments
  • Market position and status of POCT
  • Market drivers and regulations & reimbursement
  • POCT as more than IVD's
  • David Huckle

    David Huckle, Chief Executive, Adams Business Associates

    clock

    9:50

    Implementing effective POCT services strategically

    David  Wells

    David Wells, Lead Laboratory Manager and Lead Healthcare Scientist, Great Ormond Street Hospital

    clock

    10:30

    Morning Coffee

    clock

    11:00

    Sensor technologies for mHealthcare

    Christopher Lowe

    Christopher Lowe, Director of the Institute of Biotechnology, Cambridge University

    clock

    11:40

    Point of care testing and clinical outcomes

    Maurice O'Kane

    Maurice O'Kane, Consultant, Altnagelvin Hospital

  • The impact of POCT on operational outcomes
  • The impact of POCT on financial outcomes
  • POCT as 'disruptive technology'
  • The impact of POCT on patient clinical outcomes
  • clock

    12:20

    Networking Lunch

    clock

    13:20

    Patient- controlled records for new POCT business models

    Mohammad Al-Ubaydli

    Mohammad Al-Ubaydli, CEO, Patients Know Best

  • Putting patient in control of the data allows service redesign for better clinical workflow and new business models
  • CASE STUDY: NHS Diabetes clinic with POCT of HbA1c results feeding directly into hospital institutional and patient's personal record
  • CASE STUDY: Private Laboratory clinic with 50 million tests per year able to accept POCT t new NHS sites
  • CASE STUDY: Faecal occult blood testing in patients homes combined with self assessment protocols allowing patient to decide when to conatct hospital
  • CASE STUDY: iPhone glucose monitors allowing patients to share data with clinical team in between appointments for titrating insulin regime
  • clock

    14:00

    Rapid Magneto Immunoassay

    Richard Luxton

    Richard Luxton, Director of the Institute of Bio-Sensing Technology, University Of The West Of England Bristol

  • Principle of rapid magneto immunoassay
  • Instrumentation and sample interface
  • Application areas of rapid magneto immunoassay
  • clock

    14:40

    Afternoon Tea

    clock

    15:10

    The Development of an Award Winning Point of Care Support Team across the NHS Northern Region

    Tony Gibson

    Tony Gibson, Scientific Director, Gateshead Healthcare Nhs Trust

  • Building relationships with higher education establishments and industry partners
  • Positioning 'near patient' services to benefit emerging NHS initiatives including health checks
  • Pulling the pieces together - fit for the future

     

  • clock

    15:50

    A regional program for POCT Services- More is different

    Per Simonsson

    Per Simonsson, Professor, University Hospital MAS

  • Advantages and challenges of a regional POCT System
  • Key aspects are IT, Transferability, preanalytics
  • Multi-level relationships with clinical department
  • More is different
  • clock

    16:30

    Chairman’s Closing Remarks and Close of Day One

    clock

    8:30

    Registration & Coffee

    clock

    9:00

    Chairman's Opening Remarks

    Phil Lefebvre

    Phil Lefebvre, Sr. Manager, Technical Assessment,

    clock

    9:10

    The Future of Decentralised/ POC Molecular Diagnostics

    Phil Lefebvre

    Phil Lefebvre, Sr. Manager, Technical Assessment,

  • Can molecular testing be used as a viable POCT?
  • What is the feasibility of performing these tests outside of the laboratory?
  • How accurate are these tests and what are the current and future applications?
  • clock

    9:50

    Molecular Diagnostics in Personalised Medicine

    Nigel Sansom

    Nigel Sansom, Senior Manager, NHS National Innovation Centre

  • Molecular Diagnostics tody
  • The market and current market dirvers
  • The confluence of nanobiosensors, molecular semantics and synthetic biology
  • clock

    10:30

    Morning Coffee

    clock

    11:00

    Metal Nanoparticles for optical imaging in medicine

    Jose Costa-Fernandez

    Jose Costa-Fernandez, Vice Dean of the Faculty of Chemistry, University of Oviedo

  • Metal nanoparticles for cellular labelling, In vivo  and deep tissue imaging
  • Nanoparticles and FRET for optical imaging
  • Potential toxicity associated with long- term exposure of live cells to particular luminescent nanoparticles 
  • clock

    11:40

    Understanding the need for point-of-care tests in low-resource settings

    Roger Peck

    Roger Peck, Research Scientist, PATH

  • Defining the specification of HIV self test appropriate use in Sub-Saharan Africa
  • Assessing utility of self test features in naive testing populations
  • clock

    12:20

    Networking Lunch

    clock

    13:20

    Point of Care Testing for Personalised Medicine for Infectious diseases

  • Rapid detection of infectious diseases
  • Tailoring antibiotic treatment to patient and pathogen
  • Understanding the biomarkers
  • Till Bachmann

    Till Bachmann, COO, Head of Biochip Research, University of Edinburgh

    clock

    14:00

    Tuberculosis: Working towards diagnostic solutions

    Penny Wilson

    Penny Wilson, Lead Specialist, Detection and Identification Of Infectious Agents, Technology Strategy Board

  • Tuberculosis, the challenge
  • The development of novel POC diagnostics
  • The Global dimension
  • clock

    14:40

    Afternoon Tea

    clock

    15:10

    POCT in Ambulance Care

    Brian Winn

    Brian Winn, Partner, Bitecic

  • New models of Ambulance services offer new opportunities for POCT
  • What does a paramedic need to know on arrival at a scene?
  • What POC Tests would speed decision-making for front line medics?
  • What do they expect from these devices
  • Rapid test results lead to better informed treatment therapies at the scene
  • Opportunities arising from future technologies for front line healthcare professionals
  • clock

    15:50

    Understanding critical factors for the success of new point of care diagnostics and making the most of established technologies

    John Rippeth

    John Rippeth, Principal Consultant, PA Consulting Group

  • Reconfiguration of existing technologies for new applications to ensure a better patient outcome
  • Ensuring that new technologies address more than just performance benefits
  • Understanding teh care pathway to better implement diagnostic testing
  • clock

    16:30

    Rapid molecular diagnostics for Point-of-Care

    John Clarkson

    John Clarkson, Chief Executive, ATLAS GENETICS LTD

  • Rapid integrated molecular diagnostics technologies are becoming commercially available
  • These have the potential to positively impact patient care
  • Application areas include infectious disease, coagulation and companion diagnostics
  • This talk will discuss recent advances in this area, using the Atlas io™ system as an example, with specific focus on applications in diagnosis of sexually transmitted infections

     

  • clock

    17:10

    Chairman’s Closing Remarks and Close of Day Two


    Partner
    Bitecic
    Director of the Institute of Biotechnology
    Cambridge University
    Lead Laboratory Manager and Lead Healthcare Scientist
    Great Ormond Street Hospital
    Chief Executive
    Adams Business Associates
    Chief Executive
    ATLAS GENETICS LTD
    Principal Consultant
    PA Consulting Group
    Vice Dean of the Faculty of Chemistry
    University of Oviedo
    Consultant
    Altnagelvin Hospital
    CEO
    Patients Know Best
    Senior Manager
    NHS National Innovation Centre
    Lead Specialist, Detection and Identification Of Infectious Agents
    Technology Strategy Board
    Professor
    University Hospital MAS
    Sr. Manager, Technical Assessment
    Director of the Institute of Bio-Sensing Technology
    University Of The West Of England Bristol
    Research Scientist
    PATH
    COO, Head of Biochip Research
    University of Edinburgh
    Scientific Director
    Gateshead Healthcare Nhs Trust

    Marriott Regents Park

    128 King Henry's Road
    London NW3 3ST
    United Kingdom

    Marriott Regents Park

    This 4 star north London hotel in zone 2 is the perfect destination for the astute business traveler as well as the leisure guest that knows how convenient north London hotels are, as a base from which to explore the city .Bond Street is just 3 stops from Swiss Cottage underground station on the Jubilee Line, so you can be shopping, exploring the sights and taking in one of London’s world-renowned West End shows in less than 15 minutes when you stay at this hotel near central London. At the same time, the hive of activity that is Camden Town, the chic shops, cafes and restaurants of Primrose Hill and ZSL’s London Zoo in Regents Park are all just a short walk from this hotel in north London.

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download

    Title


    Description

    Download

    Title


    Description


    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SAE Media Group

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smgconferences.com Email: events@saemediagroup.com
    Registered in England - SMi Group Ltd trading as SAE Media Group




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out

    Fill in your details to download the brochure

    By submitting this form you agree to our privacy policy and consent to receiving communications, you may opt out at any time.